ISRG.NEO Intuitive Surgical CDR (CAD Hedged)
- Market cap
- CAD 219B
- P/E
- 49.8x
- P/B
- 8.23x
- ROE
- 18.0%
- Dividend yield
- -
- Fundamental score
- 1.6/5
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ISRG.NEO undervalued?
Graham numberThe Graham number of Intuitive Surgical CDR (CAD Hedged) cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Intuitive Surgical CDR (CAD Hedged) fundamental analysis
8 of 22 checks passedROE 1/2
Moderate return on equity (18.0%), between 10% and 20%.
ROA 1/1
Return on assets (14.9%) is above the industry median (2.1%).
Profit Consistency 1/2
Profitable for 4 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (23.5%) is above the industry median (5.0%).
Revenue Growth 2/2
Revenue grew 17.4% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
No interest expense reported.
PE vs Market 0/1
PE (54.9x) is above the market median (20.3x).
PE vs Industry 0/1
PE (54.9x) is above the industry median (30.3x).
PBV 0/1
Price to book (9.1x) is above the industry median (1.5x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 497.3, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Intuitive Surgical CDR (CAD Hedged) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Intuitive Surgical CDR (CAD Hedged)
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimal…
Full company profileIntuitive Surgical CDR (CAD Hedged) financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Intuitive Surgical CDR (CAD Hedged) annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 6.22B | 7.12B | 8.35B | 10.1B | 11.6B |
| Gross Profit | 4.20B | 4.73B | 5.63B | 6.64B | 7.83B |
| Operating Income | 1.58B | 1.77B | 2.35B | 2.95B | 3.83B |
| EBITDA | 1.94B | 2.22B | 2.85B | 3.62B | 4.69B |
| Net Income | 1.32B | 1.80B | 2.32B | 2.86B | 2.88B |
| EPS | 3.78 | 5.10 | 6.51 | 8.04 | 8.16 |
| Balance Sheet | |||||
| Total Assets | 13.0B | 15.4B | 18.7B | 20.5B | 19.3B |
| Total Liabilities | 1.86B | 2.04B | 2.21B | 2.52B | 3.23B |
| Shareholders' Equity | 11.0B | 13.3B | 16.4B | 17.8B | 16.0B |
| Cash & Short-term Investments | 1.58B | 2.75B | 2.03B | 3.37B | 2.98B |
| Cash Flow | |||||
| Operating Cash Flow | 1.49B | 1.81B | 2.42B | 3.03B | 4.26B |
| Capital Expenditure | 532M | 1.06B | 1.11B | 540M | 439M |
| Free Cash Flow | 958M | 750M | 1.30B | 2.49B | 3.82B |
| Ratios | |||||
| ROE | 12.0% | 13.5% | 14.1% | 16.0% | 18.0% |
| ROA | 10.2% | 11.6% | 12.4% | 14.0% | 14.9% |
| Net Profit Margin | 21.3% | 25.2% | 27.8% | 28.4% | 24.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Intuitive Surgical CDR (CAD Hedged) dividends
Intuitive Surgical CDR (CAD Hedged) has not paid dividends in the last 5 fiscal years.
Who owns Intuitive Surgical CDR (CAD Hedged)
Ownership data of Intuitive Surgical CDR (CAD Hedged) is not available yet.
Intuitive Surgical CDR (CAD Hedged) company profile
- Company name
- Intuitive Surgical CDR (CAD Hedged)
- Ticker
- ISRG.NEO
- Exchange
- NEO Exchange
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Employees
- 15,638
- Fiscal year end
- December
- Address
- 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304
- Phone
- 408 523 2100
- Website
- intuitive.com
About Intuitive Surgical CDR (CAD Hedged)
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Intuitive Surgical CDR (CAD Hedged) management
10- Dr. Gary S. Guthart Ph.D.Executive Chair · born 1966
- Mr. David J. RosaCEO & Director · born 1968
- Mr. Jamie E. SamathCFO, Head of Business Technology & Enterprise Technology Leader · born 1971
- Mr. Henry L. CharltonExecutive VP and Chief Commercial & Marketing Officer · born 1970
- Dr. Brian E. Miller Ph.D.Chief Digital Officer · born 1975
- Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller
- Mr. Milind WagleChief Information Officer
- Mr. Daniel P. Connally C.F.A.VP & Head of Investor Relations
- Mr. Gary H. Loeb J.D.Chief Legal & Compliance Officer · born 1970
- Dr. Christopher R. Carlson Ph.D.Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures